Investing
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.
The hospital-focused telehealth and virtual care delivery company, which currently works with more than 70 health systems, will use the funds to scale its reach.
The company's technology enables gesture recognition by detecting subtle muscle movements without skin contact.
The funding round brings the company's total raise to $1.86 billion since it launched in 2018.
The company offers ICHRA plans, allowing employers to offer tax-free allowances to employees, who can then choose personalized health, dental and vision benefits.
The California-based company will use the funds to expand its healthcare advocate network nationwide and accelerate its development.
The company will use the funds for AI research and to advance its programs in clinical development.
Also, South Korean medical AI companies JLK and Coreline Soft announced recent regulatory approvals in Japan and the United States.
The company, spun out of MIT and backed by Define Ventures, GV and Flare Capital Partners, was founded by veteran AI and clinical leaders from MIT, Harvard, Microsoft and Google.
The company says it partnered with child psychologists to develop an online safety platform for individuals and families to protect children from "technology's negative effects."